Trupanion, Inc. (NASDAQ:TRUP) Receives $46.60 Consensus PT from Analysts

Trupanion, Inc. (NASDAQ:TRUP) has earned an average recommendation of “Moderate Buy” from the seven ratings firms that are covering the firm, MarketBeat.com reports. Two analysts have rated the stock with a hold recommendation, four have given a buy recommendation and one has given a strong buy recommendation to the company. The average 12 month price target among brokerages that have issued ratings on the stock in the last year is $46.60.

TRUP has been the subject of several analyst reports. Stifel Nicolaus decreased their price objective on Trupanion from $44.00 to $41.00 and set a “hold” rating for the company in a report on Thursday, February 20th. Piper Sandler cut their target price on shares of Trupanion from $57.00 to $52.00 and set an “overweight” rating for the company in a research note on Thursday, February 20th.

Insider Activity at Trupanion

In related news, CFO Fawwad Qureshi sold 1,373 shares of the firm’s stock in a transaction dated Wednesday, February 26th. The shares were sold at an average price of $34.22, for a total value of $46,984.06. Following the completion of the sale, the chief financial officer now directly owns 2,416 shares in the company, valued at approximately $82,675.52. This trade represents a 36.24 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Margaret Tooth sold 2,294 shares of the firm’s stock in a transaction that occurred on Tuesday, March 4th. The stock was sold at an average price of $31.39, for a total transaction of $72,008.66. Following the sale, the chief executive officer now owns 118,784 shares of the company’s stock, valued at $3,728,629.76. This trade represents a 1.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 3,859 shares of company stock worth $128,593. Insiders own 5.50% of the company’s stock.

Institutional Investors Weigh In On Trupanion

Several hedge funds have recently bought and sold shares of the stock. Vanguard Group Inc. lifted its position in Trupanion by 1.3% during the fourth quarter. Vanguard Group Inc. now owns 3,596,725 shares of the financial services provider’s stock worth $173,362,000 after acquiring an additional 45,653 shares during the last quarter. Wellington Management Group LLP lifted its position in Trupanion by 4.4% during the third quarter. Wellington Management Group LLP now owns 3,393,879 shares of the financial services provider’s stock worth $142,475,000 after acquiring an additional 142,156 shares during the last quarter. FMR LLC lifted its position in Trupanion by 55,963.7% during the third quarter. FMR LLC now owns 1,172,293 shares of the financial services provider’s stock worth $49,213,000 after acquiring an additional 1,170,202 shares during the last quarter. Marshall Wace LLP lifted its position in Trupanion by 6.9% during the fourth quarter. Marshall Wace LLP now owns 901,645 shares of the financial services provider’s stock worth $43,459,000 after acquiring an additional 57,804 shares during the last quarter. Finally, Balyasny Asset Management L.P. lifted its position in Trupanion by 368.2% during the fourth quarter. Balyasny Asset Management L.P. now owns 841,254 shares of the financial services provider’s stock worth $40,548,000 after acquiring an additional 661,559 shares during the last quarter.

Trupanion Price Performance

Shares of NASDAQ TRUP opened at $33.88 on Thursday. The stock has a market capitalization of $1.43 billion, a price-to-earnings ratio of -147.30, a PEG ratio of 6.02 and a beta of 1.60. The business has a 50-day moving average of $44.82 and a 200-day moving average of $47.65. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.71 and a quick ratio of 1.66. Trupanion has a fifty-two week low of $19.69 and a fifty-two week high of $57.90.

Trupanion (NASDAQ:TRUP) last announced its quarterly earnings data on Wednesday, February 19th. The financial services provider reported $0.04 earnings per share for the quarter, missing the consensus estimate of $0.06 by ($0.02). The company had revenue of $337.31 million during the quarter, compared to the consensus estimate of $335.41 million. Trupanion had a negative net margin of 0.75% and a negative return on equity of 3.08%. As a group, sell-side analysts predict that Trupanion will post 0.13 earnings per share for the current fiscal year.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.